Kin Health | $9,000,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Certified by Founder
Lodge
AvenCell
start up
United States
- Cambridge, Massachusetts
- 22/10/2024
- Series B
- $112,000,000
Based on our deep science and focused on patients in need, we develop next generation immunotherapies for hard-to-treat cancers.
- Industry Biotechnology
- Website https://avencell.com/
- LinkedIn https://www.linkedin.com/company/avencell/
Hellbender Inc. | $12,500,000 | (May 20, 2026)
Rely | $4,500,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
viktor.com | $75,000,000 | (May 20, 2026)
Brami Inc. | $33,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)